Charles River Laboratories 

Ramin Baghirzade, Ph.D., Global Head Commercial, Gene Therapy CDMO Services 

Oct. 12 | 2:00pm | Oxford Biomedica Ballroom 

Wilmington, MA 

(NASDAQ: CRL) 

In-person Presentation 

A CRO/CDMO with 75 years experience bringing therapeutics to market. Charles River now has a concept-to-commercial portfolio in cell and gene therapy enabling partners to reduce the number of complex external relationships which need to be managed. This serves to simplify the CRO/CDMO relationship and speed time to clinic and commercial. 

www.criver.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions